Apigenin vs Melatonin: Which Is Better for Sleep?
Melatonin, dosed low. It scores 8.2 against apigenin's 6.7 and wins the sleep rows outright. The morning hangover apigenin markets against comes from taking too much, not from…
- Apigenin
- Melatonin
Best Interventions for Kids, Ranked by Evidence
Every intervention Outliyr has scored for kids, ranked by its BioHarmony score for this use case rather than its overall rating. The number beside each name is how well that one thing works for kids; the tier beside it is what it is worth once safety, cost and effort are counted across everything else.
26 of 75 evaluated interventions score 3.0+ out of 10 for kids · 3 comparisons
Ranked for Kids
Category
-
Lactoferrin
Pediatric is a 8.0/10 fit for Lactoferrin, based on the evidence summarized in Tarnow-Mordi et al. 2020. Pediatric evidence is stronger than general adult evidence because lactoferrin is a milk protein with…
Read the Lactoferrin report → -
HRV Biofeedback
A 7.0/10 pediatric rating fits HRV Biofeedback, since Lehrer et al. 2020 points to a real but bounded effect. Systematic reviews confirm feasibility and efficacy in children aged 6 and up; safe…
Read the HRV Biofeedback report → -
Whole-Body Vibration
The pediatric use case for Whole-Body Vibration scores 7.0/10, reflecting data from Cai et al. 2023 showing functional gains in children with cerebral palsy Cai et al. 2023. Whole-Body Vibration is being…
Read the Whole-Body Vibration report → -
Ketogenic Diet
The pediatric case for Ketogenic Diet lands at 7.0/10 because the evidence points to a plausible use case without proving a universal response. Leung GKW et al. 2025 is the best anchor…
Read the Ketogenic Diet report → -
Melatonin
Melatonin has meaningful pediatric sleep evidence in autism and ADHD contexts, but pediatric use needs stricter oversight because accidental ingestion has become common. A meta-analysis in autism found sleep-onset latency improved by…
Read the Melatonin report → -
Zone 2 Cardio
Zone 2 Cardio earns 6.0/10 for pediatric because Kodama 2009 is the cleanest verified anchor for this report. The existing rationale points to this narrower claim: Aerobic fitness in childhood predicts later…
Read the Zone 2 Cardio report → -
Phosphatidylserine
For readers tracking pediatric, Phosphatidylserine deserves 6.0/10 because Hellhammer et al. 2004 gives the strongest anchor. Pediatric evidence is meaningful but adjunctive. Manor 2012 tested PS-omega-3 in 200 children, Hirayama 2014 tested…
Read the Phosphatidylserine report → -
Semaglutide
Pediatric scoring is 6.0/10 because Semaglutide has adolescent obesity relevance, but this category needs stricter oversight than adult weight loss. FDA 2024 reflects the seriousness of prescription indications, even though this cited…
Read the Semaglutide report → -
Metformin
Metformin receives a pediatric use-case score of 5.5/10, based on the modest FDA approval for type 2 diabetes in adolescents and limited trial data such as the Diabetes Prevention Program showing a…
Read the Metformin report → -
Electrolytes
For pediatric, Electrolytes lands at 5.0/10 because Sacks 2001 supports the strongest part of the claim. The existing rationale points to this narrower claim: Oral rehydration solution is standard for pediatric diarrheal…
Read the Electrolytes report → -
Norwegian 4×4
Pediatric use lands at 5.0/10 for Norwegian 4x4 because the protocol was designed for adults and has limited direct child-specific evidence Helgerud 2007. Adolescents can benefit from intervals when intensity is scaled,…
Read the Norwegian 4×4 report → -
Omega-3
Population fit explains the 5.0/10 pediatric score for Omega-3 because the evidence points to a plausible use case without proving a universal response. Chang et al. 2023 is the best anchor here…
Read the Omega-3 report → -
Piracetam (Nootropil)
Piracetam scores 5.0/10 for pediatric because the strongest narrow evidence involves breath-holding-spell literature rather than adult enhancement. The strongest support comes from Cohen P. et al. 2020, but the practical rating stays…
Read the Piracetam (Nootropil) report → -
Glycine
No broad pediatric supplementation evidence. Pediatric use should stay clinician-directed.
Read the Glycine report → -
Ca-AKG (Calcium Alpha-Ketoglutarate)
No pediatric Ca-AKG evidence. Pediatric use should be avoided outside clinician-directed metabolic or nutrition contexts.
Read the Ca-AKG (Calcium Alpha-Ketoglutarate) report → -
Essential Amino Acids
No pediatric indication was verified. Children with amino-acid metabolism disorders can be harmed by inappropriate amino acid intake.
Read the Essential Amino Acids report → -
L-Theanine
Lyon 2011 supports pediatric ADHD sleep use, but pediatric use should be clinician-guided and not generalized beyond that evidence.
Read the L-Theanine report → -
Colostrum
Pediatric evidence is mixed and medical-context dependent. Sangild 2021 reviews potential pediatric gut and infection uses, while Yao 2026 cautions against recommending bovine colostrum for preterm feeding intolerance based on current RCT…
Read the Colostrum report → -
Sodium Butyrate
Some pediatric IBS and IBD trial data exists, mixed, and only in clinical contexts.
Read the Sodium Butyrate report → -
Rapamycin
Pediatric disease use exists in specific specialist contexts, but healthy pediatric optimization is unsupported and inappropriate.
Read the Rapamycin report → -
Blood-Flow Restriction Training
Adolescent athlete use exists, but pediatric evidence is limited and should be supervised.
Read the Blood-Flow Restriction Training report → -
Saffron
Lopresti 2018 tested affron in youth anxiety and depressive symptoms, but pediatric evidence is too narrow for broad use without clinician guidance.
Read the Saffron report → -
Thymosin Alpha-1
Some pediatric immune-deficiency contexts exist historically, but thymosin alpha-1 is not a default pediatric intervention. Pediatric use requires specialist supervision.
Read the Thymosin Alpha-1 report → -
Semax
Tsai 2007 discusses ADHD and Rett syndrome potential, but it is hypothesis-level support rather than pediatric clinical validation outside Russian practice.
Read the Semax report → -
Hyperbaric Oxygen Therapy
Pediatric medical indications exist in specialist care contexts. Autism and general pediatric neurodevelopment claims are weak and controversial. Rossignol 2009 reports short-term behavioral changes that have not held up in later reviews.…
Read the Hyperbaric Oxygen Therapy report → -
Celebrex (Celecoxib)
FDA-approved for juvenile rheumatoid arthritis in children 2 years and older, but pediatric use requires dosing and safety oversight. CYP2C9 poor metabolizers need special caution.
Read the Celebrex (Celecoxib) report →
Nothing matches those filters.
Comparisons that judge kids
Head-to-head reports and category rankings that name a winner on this use case.
Ashwagandha vs L-Theanine: Which Is Better for Stress?
Both score anxiety 7.5, so the tie-breaker is time. L-theanine works in about an hour and you take it when you need it. Ashwagandha takes eight weeks and…
- Ashwagandha
- L-Theanine
Lactoferrin vs Colostrum: Which Is Better for Immunity?
Lactoferrin scores 7.3 against colostrum's 6.8, and lactoferrin is one protein inside colostrum. Buy lactoferrin when iron handling, acne or H. pylori is the target, at $25 to…
- Lactoferrin
- Colostrum
Questions about kids
What scores highest for kids?
Lactoferrin, at 8.0 out of 10 for kids. Pediatric is a 8.0/10 fit for Lactoferrin, based on the evidence summarized in Tarnow-Mordi et al.
What is the cheapest thing that works for kids?
Of the top-scoring options, Glycine is the least expensive at about $2 a month, scoring 4.5 out of 10 for kids.
How many interventions has Outliyr scored for kids?
26 of the 75 interventions evaluated for kids score 3.0 out of 10 or better, which is the cut-off for appearing on this page.
